Immunocore Holdings PLC (IMCR) Stock Price, Quote, News & History

IMCRNASDAQ
$30.64
-0.08-0.26%
At close: Sep 25, 5:00 PM EST
$30.60
-0.12-0.39%
Pre-Market: 6:32 AM EST

Immunocore Holdings (IMCR) Stock Price, Quote, News & History | Benzinga

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-34.96M
Investing Cash Flow (TTM)
7.81M
Financing Cash Flow (TTM)
23.29M
Free Cash Flow (TTM)
-41.15M
Capital Expenditure (TTM)
-6.20M
Net Change in Cash (TTM)
-3.86M

Analyst Trends and Forecast

2
Apr
1
1
Aug
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
3.7
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$1.13B
PE Ratio (TTM)
-
PE Ratio (FWD)
23.04
PEG Ratio (TTM)
-
PS Ratio (TTM)
3.68
PB Ratio (TTM)
3.76
Earnings Yield % (TTM)
-1.17%
Earnings Yield % (FWD)
4.34%
EV / EBITDA (TTM)
86.86
Price / EBITDA (TTM)
121.48
Price / Free Cash Flow (TTM)
-
Book Value / Share
$8.15

Company Debt

Total Debt
$394.21M
LT Debt
$394.21M
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$484.92M
Debt to Equity
1.04
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
-
Close
$30.64
Volume / Avg.
0 / 465.38K
Day Range
- - -
52 Wk Range
27.56 - 40.71
Market Cap
$1.58B
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
29
Short Interest
16.76%
Days to Cover
20.56

About

Sector
Health Care
Industry
Biotechnology
Immunocore Holdings PLC is a commercial-stage biotechnology company. Using its ImmTAX platform, the company is developing a deep pipeline in multiple therapeutic areas, including clinical stage programs in oncology and infectious disease, pre-clinica...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

FAQ

Q

How do I buy Immunocore Holdings (IMCR) stock?

A

You can purchase shares of Immunocore Holdings (NASDAQ:IMCR) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Immunocore Holdings (IMCR) competitors?

Q

What is the forecast, or price target, for Immunocore Holdings (IMCR) stock?

A

Immunocore Holdings has a consensus price target of $63.63.

Q

What is the current price for Immunocore Holdings (IMCR)?

A

The stock price for Immunocore Holdings (NASDAQ: IMCR) is $30.6 last updated September 28, 2026 at 8:12 AM EDT.

Q

Does Immunocore Holdings (IMCR) pay a dividend?

A

There are no upcoming dividends for Immunocore Holdings.

Q

When is Immunocore Holdings (NASDAQ:IMCR) reporting earnings?

A

Immunocore Holdings does not have any upcoming earnings scheduled.

Q

Is Immunocore Holdings (IMCR) going to split?

A

There is no upcoming split for Immunocore Holdings.

Q

What sector and industry does Immunocore Holdings (IMCR) operate in?

A

Immunocore Holdings is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.